State Policy Philadelphia Physician Outlines Unintended Consequences of the Proposed… Thomas Sullivan Dec 13, 2018 0 Yesterday we covered an update on the legislation Philadelphia City Councilman Bill Greenlee introduced that would ban gifts from…
State Policy Philadelphia Pharmaceutical “Gift” Ban and Rep License Bill Moves Through… Thomas Sullivan Dec 12, 2018 0 We previously posted about the legislation Philadelphia City Councilman Bill Greenlee introduced that would ban gifts from…
Anti Kickback Medtronic Subsidiaries Plead Guilty and Settle Various Allegations Thomas Sullivan Dec 11, 2018 0 On December 4, 2018, the United States Department of Justice announced settlements with two of Medtronic’s subsidiaries, Covidien…
CME IFPMA Ethics Code Revised, Aligns with PhRMA Code, Bans Entertainment and… Thomas Sullivan Dec 10, 2018 0 The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) released a new Industry Code of Practice,…
Compliance HHS OIG Issues Unfavorable Opinion Regarding Drug Company’s Plan to Provide… Thomas Sullivan Dec 7, 2018 0 On November 16, 2018, the Office of the Inspector General of the Department of Health and Human Services (HHS-OIG) released…
Congress House Democrats Introduce Bill to Stem Healthcare Violence Thomas Sullivan Dec 6, 2018 0 On November 19, 2018, a Chicago police officer was killed in the line of duty as he was responding to a gunfire attack on Mercy…
Conflict of Interest Recent Study on Inconsistencies in Self-Declared Conflicts of Interests Thomas Sullivan Dec 5, 2018 0 Recently, JAMA published an investigative study on the inconsistencies between self-declared conflicts of interests as compared to…
FDA FY 2018: More Generic Drug Approvals Than Ever Before Thomas Sullivan Dec 4, 2018 0 In October 2018, United States Food and Drug Administration (FDA) announced that it had approved – and tentatively approved – more…
DTC FDA Releases Draft Guidance on DTC Advertising Thomas Sullivan Dec 3, 2018 0 In October 2018, the United States Food and Drug Administration (FDA) released a draft guidance on how to present efficacy and…
CMS CMS Issues Proposed Rule Focused on Part D and MA Drug Prices Thomas Sullivan Nov 30, 2018 0 On Monday, the Centers for Medicare and Medicaid Services (CMS) announced a proposed rule and opened comments that attempts to…